When people think about increasing temperatures, they often consider the effects on people in terms of natural disasters or ...

Urolithiasis is a highly prevalent and multifactorial disease, representing the most common urological condition globally.

THIS YEAR the Spanish capital, Madrid, provided the backdrop for Europe’s biggest urological event, the 40th Annual European ...

An investigator reported updated findings from the phase 2/3 study QUILT 3.032 using a July 15, 2024 data cutoff.

Oncologic Outcomes in Patients Undergoing Radical Cystectomy for non–muscle-invasive bladder cancer (NMIBC) Following BCG Therapy Failure. Dr. Oberneder highlighted that the U.S. FDA has approved ...

The safety profile of cretostimogene was reported to be well-tolerated, with no grade 3 or greater treatment-related adverse ...

Dr. Ben-David began his presentation by highlighting that tumor-informed circulating tumor DNA (ctDNA) has emerged as a novel prognostic biomarker in bladder cancer. His team sought to evaluate ...

The ongoing phase 2b SunRISe-1 study is assessing TAR-200 intravesical gemcitabine delivery in patients with BCG-unresponsive high-risk NMIBC.

The key takeaways are that prostate cancer misinformation is widespread across online platforms and spans many different ...

Lead investigational program, NDV-01, for High-Grade Non-Muscle Invasive Bladder Cancer, is being evaluated in a Phase 2 study. In addition, preparations are underway to advance sepranolone, a Phase ...